Loading... Please wait...

Our Newsletter

Carl Zeiss Meditec Intrabeam Intraoperative Radiotherapy

  • Carl Zeiss Meditec Intrabeam Intraoperative Radiotherapy
In Stock
Free Shipping
Minimum Purchase:
1 unit(s)
Bookmark and Share

Product Description

Focusing on your patient ZEISS helps you provide patients with safe cancer treatment options in addition to the conventional standard of care. Combining faster cancer treatment courses and reducing the associated side effects provides gentle treatments for patients – a key element to increasing their quality of life.1Targeted effectiveness without delayIORT from ZEISS enables an effective high-dose cancer treatment option, delivered directly during surgery and precisely where it is needed. Local irradiation of the tumor or the tumor bed can be prescribed as a single definitive treatment, or as a boost treatment combined with external beam radiotherapy for high-risk patients.1Unifying proven IORT advantages in one solution Low-energy X-rays have a high relative biological effectiveness due to the higher ionization density of radiation in tissue compared to megavolt X-rays. Additionally, due to the steep dose falloff the tissue of interest is irradiated in a way that reduces collateral damage, which is a special characteristic of low-energy radiation. Therefore radiation can be applied immediately to well-vascularized tissue after R0 resection and also after incomplete tumor resections in R1 and R2 scenarios.2, 3

Intraoperative radiotherapy (IORT) is where the patient is given a single dose of radiotherapy during their operation for breast cancer. This negates the need for a 3-5 week course of radiotherapy treatment post operation for suitable patients.

The length of the operation is not extended. In HHFT, during the operation, samples are taken of sentinel nodes and sent to the laboratory for analysis. The surgeon waits for the results before continuing with the operation. The IORT treatment can be administered whilst waiting for those results.

This is cutting edge technology; HHFT will be one of only two district hospitals in the UK able to offer intra-operative radiotherapy and intra-operative sentinel node analysis (OSNA) simultaneously; effectively this is one-stop surgery and radiotherapy, as a day case procedure.

Two additional factors are driving HHFT’s lead in the South of England in delivering IORT. One is that there is the potential to be involved in the IORT training academy. Second is the legal case of Montgomerie versus Lanarkshire which has set a new standard for patient consent – this means that patients must be informed of alternatives to whole breast radiotherapy outside of HHFT. If we are not able to offer this procedure, patients may opt to go elsewhere.

Warranty Information

2 Years Warranty

Find Similar Products by Tag

Find Similar Products by Category

Write your own product review

Product Reviews

This product hasn't received any reviews yet. Be the first to review this product!

Add to Wish List

Click the button below to add the Carl Zeiss Meditec Intrabeam Intraoperative Radiotherapy to your wish list.

You Recently Viewed...